Overview

Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease

Status:
Recruiting

Trial end date:
2022-12-30

Target enrollment:

Participant gender:

Summary

EFFECTIVENESS OF COMBINED ANTICOAGULATION AND ANTITHROMBOTIC THERAPY VS ANTITHROMBOTIC THERAPY ALONE AFTER LOWER EXTREMITY REVASCULARIZATION FOR PERIPHERAL ARTERIAL DISEASE.

Phase:

Early Phase 1

Details

Lead Sponsor:

Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi

Treatments:

Rivaroxaban